Astellas Pharma US, Inc. and The International Transplant Nurses Society (ITNS) Collaborate on Content for Transplant Experience Program

Thursday, October 18, 2007 General News
Email Print This Page Comment bookmark
Font : A-A+

DEERFIELD, Ill., Oct. 17 Astellas Pharma US,Inc. (Pink Sheets: ALPMF), a leader in the field of transplantation, and TheInternational Transplant Nurses Society (ITNS), a leading transplantprofessional organization, announced a collaborative partnership to jointlydevelop further materials for the multi-award-winning Transplant Experienceprogram -- a comprehensive, educational resource for the transplant community.

"The International Transplant Nurses Society (ITNS) endorses theTransplant Experience program and is proud to be a collaborative partner withAstellas," said Beth A. Kassalen, Executive Director of ITNS. "We are excitedto be able to develop materials that empower organ transplant recipients andtheir caregivers to take a more active role in their treatment and long-termhealth."

The Transplant Experience program offers a variety of tools to helpempower patients and caregivers, providing resources throughout every stage ofthe transplant experience: pre-transplant, the first year after a transplant,and beyond. The program includes, tools, tips and also provides peer-to-peerinformation from transplant recipients. Materials are available at or by calling 1-800-466-9191, and include:

"Educating the patient community and sharing scientific knowledge withhealthcare professionals, such as transplant nurses, is Astellas'responsibility as a leader in the field of transplantation," said M. RoyFirst, M.D., Vice President, Global Immunology, Astellas Pharma US, Inc. "Thispartnership further strengthens our relationship with the transplant communityand provides vital information to patients and caregivers about the transplantexperience."

The first piece developed jointly by ITNS and Astellas is a brochure,"Kidney Function and Your New Organ," available both in a hard copy format,and a downloadable version through

About ITNS

The International Transplant Nurses Society was founded in 1992 as thefirst professional nursing organization to promote the education and clinicalpractice excellence of nurses caring for solid organ transplant patients.Today, ITNS is a leading transplant organization with more than 1,400 activemembers representing 29 countries around the world.

A vital component of countless nursing careers, ITNS provides a forum forlearning about the most current advances in transplantation and transplantpatient care. Over the years ITNS has provided skilled transplant nurses theopportunity to share and learn with national and international peers and toreceive recognition for their knowledge, leadership, and scholarly pursuits.

About Astellas

Astellas is a recognized leader in transplantation and has been committedto the field of immunology for more than 20 years. Dedicated to supporting theadvancement of care for patients, Astellas continues to build upon its legacyand leadership in transplantation by investing in ongoing clinical researchand new product development.

Astellas Pharma US, Inc., located in Deerfield, Illinois, is a U.S.affiliate of Tokyo-based Astellas Pharma Inc., Astellas is a pharmaceuticalcompany dedicated to improving the health of people around the world throughthe provision of innovative and reliable pharmaceutical products. Theorganization is committed to becoming a global category leader in focusedareas by combining outstanding R&D and marketing capabilities. In the US,Astellas markets products in the areas of Immunology, Urology,Anti-Infectives, Cardiovascular and Dermatology. For more information aboutAstellas Pharma US, inc., please visit our website at Welcome kit, including an inspirational video, a personal treatment journal and a unique pill box to help patients organize and carry their medicines -- Helpful information sent directly to pa

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store